In 1986, concerned that indigent and uninsured patients were not receiving proper emergency treatment, Congress enacted the Emergency Medical Treatment and Active Labor Act (“EMTALA”), designed to prevent hospitals from “patient dumping.” To determine when the statute applies, federal courts have had to interpret what constitutes an “emergency medical condition,” and ascertain the category of individuals protected by the act. In Torretti v. Main Line Hospitals, Inc ., 580 F.3d 168 (2009), the United States Court of Appeals for the Third Circuit confronted these issues for the first time.

EMTALA sets forth two requirements for hospitals that participate in Medicare and provide emergency care. First, hospitals must provide appropriate medical screening to determine if an emergency medical condition exists for any individual who presents to an emergency department. Second, if an emergent condition is apparent, treatment must be provided to “stabilize” the patient. Accordingly, one of the primary objectives of EMTALA is to remedy the problem of inappropriate hospital transfers. If arrangements are made to transfer an individual to another medical facility, the patient must be stabilized prior to transfer. EMTALA does not create a federal claim for malpractice, but is determined independent of any such claims which are typically adjudicated in state courts.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]